BR9806250A - Busesonde isolated or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases. - Google Patents

Busesonde isolated or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases.

Info

Publication number
BR9806250A
BR9806250A BR9806250-6A BR9806250A BR9806250A BR 9806250 A BR9806250 A BR 9806250A BR 9806250 A BR9806250 A BR 9806250A BR 9806250 A BR9806250 A BR 9806250A
Authority
BR
Brazil
Prior art keywords
therapy
isolated
combination
busesonde
liver diseases
Prior art date
Application number
BR9806250-6A
Other languages
Portuguese (pt)
Inventor
Maria Leuschner
Original Assignee
Falk Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742612A external-priority patent/DE19742612A1/en
Priority claimed from DE29717252U external-priority patent/DE29717252U1/en
Application filed by Falk Pharma Gmbh filed Critical Falk Pharma Gmbh
Publication of BR9806250A publication Critical patent/BR9806250A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"BUDESONIDA ISOLADA OU EM COMBINAçãO COM áCIDO URSODESOXICóLICO NA TERAPIA DE DOENçAS HEPáTICAS COLESTáTICAS"<D>. De acordo com a invenção, verificou-se inesperadamente que a budesonida pode ser usada para o tratamento de doenças hepáticas colestáticas, como CBP, CEP e CA. Em particular, a budesonida é altamente eficaz quando juntamente com ácido ursodesoxicólico.Invention Patent: <B> "BUDESONIDE ISOLATED OR IN COMBINATION WITH URSODESOXICOLIC ACID IN THE THERAPY OF CHOLESTATIC HEPATIC DISEASES" <D>. According to the invention, it has unexpectedly been found that budesonide can be used for the treatment of cholestatic liver diseases, such as CBP, CEP and CA. In particular, budesonide is highly effective when combined with ursodeoxycholic acid.

BR9806250-6A 1997-09-26 1998-09-02 Busesonde isolated or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases. BR9806250A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19742612A DE19742612A1 (en) 1997-09-26 1997-09-26 Budesonide for the treatment of cholestatic liver diseases
DE29717252U DE29717252U1 (en) 1997-09-26 1997-09-26 Drug kit consisting of a budesonide-containing and an ursodeoxycholic acid-containing drug for the treatment of cholestatic liver diseases
CA002216887A CA2216887C (en) 1997-09-26 1997-09-30 Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases
US08/940,211 US5858998A (en) 1997-09-26 1997-09-30 Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases
PCT/EP1998/005567 WO1999016429A2 (en) 1997-09-26 1998-09-02 Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases

Publications (1)

Publication Number Publication Date
BR9806250A true BR9806250A (en) 2000-01-25

Family

ID=27427393

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9806250-6A BR9806250A (en) 1997-09-26 1998-09-02 Busesonde isolated or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases.

Country Status (2)

Country Link
BR (1) BR9806250A (en)
WO (1) WO1999016429A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3760203A1 (en) 2019-07-03 2021-01-06 Medizinische Universität Graz Medicament for prevention or treatment of a metabolic disorder

Also Published As

Publication number Publication date
WO1999016429A2 (en) 1999-04-08
WO1999016429A3 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
BRPI0411319A (en) therapeutically active compounds and their use
BRPI0411295A (en) compounds and their use in therapy
CA2216887A1 (en) Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases
BRPI9815772A (en) use of alkyl hydrogen fumarates for the treatment of psoriasis, psoriatic arthritis, neurodermatitis and regional crohn&#39;s enteritis
BR0113625A (en) Exemestane as a chemoprevention agent
BR9915943A (en) Controlled release formulation comprising gnrh-ii
BR0312845A (en) Tetrapropylammonium tetrathiomolybdate and related compounds for antiangiogenic therapies
BR9714059A (en) S-omeprazole in a neutral form, process to prepare it, use of it, pharmaceutical composition, and process to treat a condition related to gastric acid.
BR9911071A (en) Preparations for the application of anti-inflammatory agents, especially antiseptics and / or agents that promote healing of wounds in the upper respiratory tract and / or the ear
PT956009E (en) TREATMENT OF NEURODEGENERATIVE DISEASES WITH NIMESULIDE
ECSP045520A (en) TREATMENT METHODS WITH PTEC INHIBITORS AND ANTIHIPERTENSIVE AGENTS
BR9912179A (en) Neuroprotective composition for the prevention and / or treatment of nervous and behavioral changes due to states of anxiety or depression
BR9711194A (en) Use of chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer&#39;s disease.
BR0107157A (en) Diagnosis and treatment of cardiovascular conditions
BR9914044A (en) tetrahydropyride esters
BRPI0410326A (en) composition comprising a pde4 inhibitor and pde5 inhibitor
BR0108514A (en) Use of il-18 inhibitors
BRPI0415753A (en) method for treating and preventing respiratory inflammation with a cyclooxygenase-2 inhibitor in combination with a phosphodiesterase 4 inhibitor and compositions containing them
BR9808140A (en) Unit formulation
BR9806892A (en) New formulation for inhalation; showing volumetric density, when poured, from 0.20 to 038 g / ml, comprising budesonide
CA2218766A1 (en) Bicyclic-aromatic compounds
BR9808302A (en) The use of levobupivacaine in pediatric surgery
BRPI0408944A (en) method for providing a steroid reducing benefit with a cyclooxygenase-2 inhibitor and compositions with this
BR9806250A (en) Busesonde isolated or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases.
BR9712307A (en) Pyrazolinones for the treatment of weakened potency

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFIRO PELO PRESENTE PEDIDO DE PATENTE DE ACORDO COM ARTIGO 8O DA LPI.